PI3K Inhibition (delta, gamma) Program

We are interested in requests related to PI3K Inhibition. The phosphoinositide 3-kinase (PI3K) signaling pathway is a key regulator in cancer proliferation (rapid increase or spread) and metastasis (development of secondary growths away from a primary site of cancer). The PI3K pathway includes four Class I isoforms: alpha, beta, delta and gamma (α, β, δ, and γ). The four isoforms play unique roles in the survival of different tumor types and in the creation of supportive tumor microenvironments.

RFP Details

Products:

The UserField "IIS_RFP_PRODUCTS" was not found in the UserFields collection.

Topics of Interest:

The UserField "IIS_RFP_TOPICS_OF_INTEREST" was not found in the UserFields collection.

Regional Considerations:

The UserField "IIS_RFP_REGIONAL_CONSIDERATIONS" was not found in the UserFields collection.

Deadline for Submissions

The UserField "IIS_RFP_DEADLINE" was not found in the UserFields collection.

Applicants will be notified by:

The UserField "IIS_RFP_NOTIFICATION" was not found in the UserFields collection.

About ideaPoint.pdf

We design and manufacture technology that takes the limits off living. We support healthcare professionals to return their patients to health and mobility, helping them to perform at their fullest potential.

The content on this website may not be approved for use in your specific region or country. Smith+Nephew is not responsible for any interactions or dealings you have via this website that do not comply with applicable laws and regulations in your jurisdiction. By continuing to use this website, you acknowledge and agree the terms of this notice.

^◊Trademark of Smith+Nephew. Product information is for educational purposes only, and not all products or indications are licensed in every country.